SMT201900248T1 - Processo per la produzione di 1-[2-(2,4-dimetil - fenilsolfanil)-fenil]piperazina - Google Patents
Processo per la produzione di 1-[2-(2,4-dimetil - fenilsolfanil)-fenil]piperazinaInfo
- Publication number
- SMT201900248T1 SMT201900248T1 SM20190248T SMT201900248T SMT201900248T1 SM T201900248 T1 SMT201900248 T1 SM T201900248T1 SM 20190248 T SM20190248 T SM 20190248T SM T201900248 T SMT201900248 T SM T201900248T SM T201900248 T1 SMT201900248 T1 SM T201900248T1
- Authority
- SM
- San Marino
- Prior art keywords
- phenylsulfanyl
- piperazine
- dimethyl
- phenyl
- manufacture
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- YQNWZWMKLDQSAC-UHFFFAOYSA-N vortioxetine Chemical compound CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCNCC1 YQNWZWMKLDQSAC-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261582527P | 2012-01-03 | 2012-01-03 | |
DKPA201200006 | 2012-01-03 | ||
EP12815676.7A EP2800746B1 (en) | 2012-01-03 | 2012-12-20 | Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine |
PCT/EP2012/076377 WO2013102573A1 (en) | 2012-01-03 | 2012-12-20 | Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201900248T1 true SMT201900248T1 (it) | 2019-07-11 |
Family
ID=48744991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM20190248T SMT201900248T1 (it) | 2012-01-03 | 2012-12-20 | Processo per la produzione di 1-[2-(2,4-dimetil - fenilsolfanil)-fenil]piperazina |
Country Status (25)
Country | Link |
---|---|
US (1) | US9133144B2 (it) |
EP (1) | EP2800746B1 (it) |
JP (1) | JP6018644B2 (it) |
KR (1) | KR102008039B1 (it) |
CN (1) | CN104011034B (it) |
AU (1) | AU2012364402B2 (it) |
BR (1) | BR112014016322B8 (it) |
CA (1) | CA2860103C (it) |
CL (1) | CL2014001765A1 (it) |
CO (1) | CO7000771A2 (it) |
CY (1) | CY1121629T1 (it) |
DK (1) | DK2800746T3 (it) |
HK (1) | HK1200827A1 (it) |
HR (1) | HRP20190769T1 (it) |
IL (1) | IL233093A (it) |
LT (1) | LT2800746T (it) |
MX (1) | MX344144B (it) |
PL (1) | PL2800746T3 (it) |
RS (1) | RS58683B1 (it) |
RU (1) | RU2608307C2 (it) |
SG (1) | SG11201403835UA (it) |
SI (1) | SI2800746T1 (it) |
SM (1) | SMT201900248T1 (it) |
WO (1) | WO2013102573A1 (it) |
ZA (1) | ZA201404881B (it) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2013MU03121A (it) | 2013-09-30 | 2015-07-17 | Cadila Healthcare Ltd | |
EP2878596A1 (en) * | 2013-11-29 | 2015-06-03 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)lithium intermediates |
EP2894154A1 (en) | 2014-01-14 | 2015-07-15 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)aniline intermediates |
CN103788020B (zh) * | 2014-01-22 | 2015-11-04 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
CN103788019B (zh) * | 2014-01-22 | 2015-10-07 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
EP3099669A1 (en) | 2014-01-31 | 2016-12-07 | Egis Gyógyszergyár Zrt. | Process for the preparation of vortioxetine salts |
EP2930171A1 (en) | 2014-04-07 | 2015-10-14 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate |
CN104974110A (zh) * | 2014-04-10 | 2015-10-14 | 江苏豪森药业股份有限公司 | 1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪氢溴酸盐的新晶型及其制备方法和用途 |
CN105254590B (zh) * | 2014-05-09 | 2019-09-03 | 江苏豪森药业集团有限公司 | 沃替西汀氢溴酸盐晶型及其制备方法和用途 |
EP3141543B8 (en) * | 2014-05-09 | 2022-06-08 | Shanghai Syncores Technologies Inc. Ltd. | Vortioxetine intermediate and synthesis process thereof |
CN104059030B (zh) * | 2014-05-30 | 2016-05-04 | 镇江圣安医药有限公司 | [(苯硫烷基)-苯基]哌嗪的衍生物及其药物组合物和用途 |
CN104292183B (zh) * | 2014-09-29 | 2016-01-06 | 杨献美 | 一种抗抑郁药物沃替西汀的制备方法 |
WO2016079751A2 (en) | 2014-11-17 | 2016-05-26 | Megafine Pharma (P) Ltd. | A process for preparation of vortioxetine and polymorphs thereof |
ES2634496T3 (es) | 2014-11-21 | 2017-09-28 | Dipharma Francis S.R.L. | Proceso para la preparación de un antidepresivo y los intermedios del mismo |
CN104356092B (zh) * | 2014-11-27 | 2017-03-22 | 合肥创新医药技术有限公司 | 沃替西汀的制备方法 |
WO2016125191A2 (en) | 2015-02-04 | 2016-08-11 | Mylan Laboratories Limited | Processes for the preparation of vortioxetine hydrobromide |
US10227317B2 (en) | 2015-02-25 | 2019-03-12 | Lupin Limited | Process for the preparation of vortioxetine |
CN104650004B (zh) * | 2015-03-06 | 2017-06-06 | 中山万汉制药有限公司 | 一种氢溴酸沃替西汀的制备方法 |
CN105061364A (zh) * | 2015-08-17 | 2015-11-18 | 河北国龙制药有限公司 | 氢溴酸沃替西汀的制备方法 |
US20180237386A1 (en) * | 2015-08-19 | 2018-08-23 | Amneal Pharmaceuticals Company Gmbh | Process For Preparation Of Vortioxetine Hydrobromide |
CN106556663B (zh) * | 2015-09-30 | 2018-05-29 | 成都弘达药业有限公司 | 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪或其盐的检测方法 |
KR20190025556A (ko) | 2016-07-01 | 2019-03-11 | 하. 룬드벡 아크티에셀스카브 | 항우울 효과의 신속한 개시를 위한 보티옥세틴 투여 요법 |
US10519121B2 (en) | 2016-12-30 | 2019-12-31 | Apicore Us Llc | Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts |
CN106831652B (zh) * | 2017-01-23 | 2019-01-11 | 齐鲁天和惠世制药有限公司 | 一种沃赛汀的制备方法 |
CN108017595A (zh) * | 2017-12-20 | 2018-05-11 | 安徽源久源科技有限公司 | 一种1-[2-(2,5-二甲基苯硫基)苯基]哌嗪的制备方法 |
SI3810582T1 (sl) | 2018-06-20 | 2024-05-31 | Vio Ag Pharmaceuticals S.A. | Enolončni pristop z organo-psevdokatalitično aktivacijo c-h za pripravo vortioksetina in intermediata vortioksetina |
CN109438390A (zh) * | 2018-11-26 | 2019-03-08 | 合肥创新医药技术有限公司 | 一种氢溴酸沃替西汀杂质的合成方法 |
CN112250642A (zh) * | 2020-10-28 | 2021-01-22 | 合肥亿帆生物制药有限公司 | 一种氢溴酸伏硫西汀杂质标准品的制备方法 |
CN115368318B (zh) * | 2022-06-22 | 2023-11-03 | 山东辰龙药业有限公司 | 一种伏硫西汀的合成方法及应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07110050A (ja) | 1993-10-13 | 1995-04-25 | Daikin Mfg Co Ltd | 捩じり振動減衰装置 |
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
JP2005513128A (ja) * | 2001-12-20 | 2005-05-12 | ハー・ルンドベック・アクチエゼルスカベット | アリールオキシフェニル及びアリールスルファニルフェニル誘導体 |
KR101627901B1 (ko) * | 2006-06-16 | 2016-06-13 | 하. 룬트벡 아크티에 셀스카브 | 인지기능 장애의 치료를 위한, 세로토닌 재흡수, 5-ht3 및 5-ht1a 활성이 조합된 화합물로서의 1-[2-(2,4-디메틸페닐술파닐)-페닐]피페라진 |
TW201033181A (en) * | 2009-02-17 | 2010-09-16 | Lundbeck & Co As H | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
-
2012
- 2012-12-20 SM SM20190248T patent/SMT201900248T1/it unknown
- 2012-12-20 JP JP2014550676A patent/JP6018644B2/ja active Active
- 2012-12-20 EP EP12815676.7A patent/EP2800746B1/en active Active
- 2012-12-20 SI SI201231600T patent/SI2800746T1/sl unknown
- 2012-12-20 WO PCT/EP2012/076377 patent/WO2013102573A1/en active Application Filing
- 2012-12-20 LT LTEP12815676.7T patent/LT2800746T/lt unknown
- 2012-12-20 BR BR112014016322A patent/BR112014016322B8/pt active IP Right Grant
- 2012-12-20 DK DK12815676.7T patent/DK2800746T3/da active
- 2012-12-20 SG SG11201403835UA patent/SG11201403835UA/en unknown
- 2012-12-20 AU AU2012364402A patent/AU2012364402B2/en active Active
- 2012-12-20 CN CN201280065665.XA patent/CN104011034B/zh active Active
- 2012-12-20 KR KR1020147018202A patent/KR102008039B1/ko active IP Right Grant
- 2012-12-20 MX MX2014008052A patent/MX344144B/es active IP Right Grant
- 2012-12-20 RU RU2014131943A patent/RU2608307C2/ru active
- 2012-12-20 PL PL12815676T patent/PL2800746T3/pl unknown
- 2012-12-20 US US14/370,322 patent/US9133144B2/en active Active
- 2012-12-20 RS RS20190553A patent/RS58683B1/sr unknown
- 2012-12-20 CA CA2860103A patent/CA2860103C/en active Active
-
2014
- 2014-06-12 IL IL233093A patent/IL233093A/en active IP Right Grant
- 2014-06-27 CO CO14139608A patent/CO7000771A2/es unknown
- 2014-06-30 CL CL2014001765A patent/CL2014001765A1/es unknown
- 2014-07-02 ZA ZA2014/04881A patent/ZA201404881B/en unknown
-
2015
- 2015-02-06 HK HK15101354.1A patent/HK1200827A1/xx unknown
-
2019
- 2019-04-25 HR HRP20190769TT patent/HRP20190769T1/hr unknown
- 2019-05-07 CY CY20191100483T patent/CY1121629T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200827A1 (en) | Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)- phenyl]-piperazine 1-[2-(24--)-]- | |
EP2812298A4 (en) | IMPROVED PROCESS FOR PRODUCING 2,3,3,3-TETRAFLUOROPROPENE | |
PL2809635T3 (pl) | Sposób wytwarzania 2,3,3,3-tetrafluoropropenu | |
EP2819978A4 (en) | PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUORPROPES | |
IL245805A0 (en) | Process for purifying 5,2-dichlorophenol | |
PT2912030T (pt) | Processo melhorado de fabrico de 5-(2,6-di-4-morfolinil-4- pirimidinil)-4-trifluorometilpiridin-2-amina | |
HK1206938A1 (en) | Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456-- | |
IL267303B (en) | Method for the production of -7-(3,4-dichloro-2-fluorophenylamino)-4)-4)-1 methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one | |
HK1213262A1 (zh) | 二氧戊環- -基甲基 -吡唑- -胺的製備方法 | |
EP2814797A4 (en) | PROCESS FOR 1,3,3,3-TETRAFLUORPROPES | |
HK1201060A1 (zh) | -二甲基苯基 -丙醛的製備方法 | |
SG11201406708XA (en) | Itq-49 material, method for the production thereof and use of same | |
ME03428B (me) | Postupak za proizvodnju 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina | |
IL229669A0 (en) | Process for the preparation of 1,2,3 triazole 4 carboxamide | |
EP2931691A4 (en) | PROCESS FOR GENERATING 2,5-DIMETHYL WIRE FROM ISOBUTENE | |
PL398022A1 (pl) | Nowy fosfolipid i sposób jego otrzymywania | |
IL238829B (en) | Process for the preparation of 4-(cyclopropylmethoxy-3,5)-n-(dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide | |
PL398020A1 (pl) | Nowy fosfolipid oraz sposób jego otrzymywania |